These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35119972)

  • 1. Sexual Health-related Quality of Life in Women with Pulmonary Arterial Hypertension: Compensating for Loss.
    Yee DC; Banerjee D; Vargas SE; Allahua M; Whittenhall ME; Perry N; Ventetuolo CE; Guthrie KM
    Ann Am Thorac Soc; 2022 Jul; 19(7):1122-1129. PubMed ID: 35119972
    [No Abstract]   [Full Text] [Related]  

  • 2. Parenteral Prostanoids in Pediatric Pulmonary Arterial Hypertension: Start Early, Dose High, Combine.
    Douwes JM; Zijlstra WMH; Rosenzweig EB; Ploegstra MJ; Krishnan US; Haarman MG; Roofthooft MTR; Postmus D; Hillege HL; Ivy DD; Berger RMF
    Ann Am Thorac Soc; 2022 Feb; 19(2):227-237. PubMed ID: 34181866
    [No Abstract]   [Full Text] [Related]  

  • 3. Sexual function is impaired in women and men with pulmonary hypertension.
    Hendriks PM; Staal DP; Pastoor H; Kolpa CIA; van den Bosch AE; Post MC; Boomars KA
    Clin Res Cardiol; 2023 Jul; 112(7):981-990. PubMed ID: 37120779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sexual health and health-related quality of life among women with pulmonary arterial hypertension.
    Banerjee D; Vargas SE; Guthrie KM; Wickham BM; Allahua M; Whittenhall ME; Palmisciano AJ; Ventetuolo CE
    Pulm Circ; 2018; 8(4):2045894018788277. PubMed ID: 30124126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symptoms, impacts, and suitability of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT™) questionnaire in patients with sarcoidosis-associated pulmonary hypertension (SAPH): a qualitative interview study.
    Currie BM; Davies EW; Beaudet A; Stassek L; Kleinman L; Baughman RP
    BMC Pulm Med; 2021 Nov; 21(1):365. PubMed ID: 34772372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Female gender and pulmonary arterial hypertension: a complex relationship].
    Manes A; Palazzini M; Dardi F; D'Adamo A; Rinaldi A; Galiè N
    G Ital Cardiol (Rome); 2012 Jun; 13(6):448-60. PubMed ID: 22622125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Differences and Outcomes between Methamphetamine-associated and Idiopathic Pulmonary Arterial Hypertension in the Pulmonary Hypertension Association Registry.
    Kolaitis NA; Zamanian RT; de Jesus Perez VA; Badesch DB; Benza RL; Burger CD; Chakinala MM; Elwing JM; Feldman J; Lammi MR; Mathai SC; McConnell JW; Presberg KW; Robinson JC; Sager J; Shlobin OA; Simon MA; Kawut SM; Glidden DV; Singer JP; De Marco T;
    Ann Am Thorac Soc; 2021 Apr; 18(4):613-622. PubMed ID: 33064950
    [No Abstract]   [Full Text] [Related]  

  • 8. Haemodynamic effects of PAH-targeted therapies in pulmonary hypertension due to lung disease: A systematic review and meta-analysis.
    Farmakis IT; Vazakidis P; Doundoulakis I; Arvanitaki A; Zafeiropoulos S; Boutou A; Karvounis H; Giannakoulas G
    Pulm Pharmacol Ther; 2021 Jun; 68():102036. PubMed ID: 33979684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of the Pulmonary Hypertension Functional Classification Self-Report: a patient version adapted from the World Health Organization Functional Classification measure.
    Highland KB; Crawford R; Classi P; Morrison R; Doward L; Nelsen AC; Castillo H; Mathai SC; DuBrock HM
    Health Qual Life Outcomes; 2021 Aug; 19(1):202. PubMed ID: 34429110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perinatal Management and Long-Term Follow-up of a Primipara With Severe Pulmonary Arterial Hypertension Associated With Systemic Lupus Erythematosus.
    Song W; Chu S; Yang K; Sun X; Xia H; Mei C; Zhao Y; Wu J
    J Cardiothorac Vasc Anesth; 2022 Aug; 36(8 Pt A):2511-2517. PubMed ID: 34247927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Risk factors for death and the clinical features of different subtypes of patients with pulmonary arterial hypertension related to congenital heart disease].
    Xu ZY; Li QQ; Zhang C; Zhang HS; Gu H
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):315-322. PubMed ID: 32370483
    [No Abstract]   [Full Text] [Related]  

  • 12. Palliative care referrals in patients with pulmonary arterial hypertension: The Pulmonary Hypertension Association Registry.
    Rohlfing AB; Bischoff KE; Kolaitis NA; Kronmal RA; Kime NA; Gray MP; Bartolome S; Chakinala MM; Frantz RP; Ventetuolo CE; Mathai SC; De Marco T;
    Respir Med; 2023 Jan; 206():107066. PubMed ID: 36470050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management and prognosis of HIV-associated pulmonary arterial hypertension: 20 Years of evidence from the REHAP registry.
    Salvador ML; Rodríguez-Padial L; Soto Abánades C; Cruz Utrilla A; Barberá Mir JA; López-Meseguer M; Segovia Cubero J; Samper GJ; Blanco Vich I; Escribano-Subías P; ;
    J Intern Med; 2022 Jul; 292(1):116-126. PubMed ID: 35184348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A World of Maximalist Medicine: Physician Perspectives on Palliative Care and End-of-life for Patients With Pulmonary Arterial Hypertension.
    Brown CE; Steiner JM; Leary PJ; Curtis JR; Engelberg RA
    J Pain Symptom Manage; 2023 Apr; 65(4):e329-e335. PubMed ID: 36521765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The treatment strategy of connective tissue disease associated pulmonary arterial hypertension: Evolving into the future.
    Zhao J; Wang Q; Deng X; Qian J; Tian Z; Liu Y; Li M; Zeng X
    Pharmacol Ther; 2022 Nov; 239():108192. PubMed ID: 35461923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Impact of composite clinical worsening events on outcome of patients with pulmonary arterial hypertension associated with congenital heart disease].
    Xu ZY; Zhang HS; Li QQ; Zhang C; Gu H
    Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Mar; 50(3):282-288. PubMed ID: 35340148
    [No Abstract]   [Full Text] [Related]  

  • 17. Development of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT®) questionnaire: a new patient-reported outcome instrument for PAH.
    McCollister D; Shaffer S; Badesch DB; Filusch A; Hunsche E; Schüler R; Wiklund I; Peacock A;
    Respir Res; 2016 Jun; 17(1):72. PubMed ID: 27301413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of pulmonary arterial hypertension during pregnancy.
    Krishnathasan K; Constantine A; Rafiq I; Barradas Pires A; Douglas H; Price LC; Dimopoulos K
    Expert Rev Respir Med; 2023 May; 17(5):413-423. PubMed ID: 37159412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sexual and Reproductive Health in Women with Pulmonary Hypertension: A Qualitative Study.
    Cipolletta S; Ravasio G; Bussotti M
    Arch Sex Behav; 2022 Apr; 51(3):1647-1657. PubMed ID: 35165801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary Arterial Hypertension in Indonesia: Current Status and Local Application of International Guidelines.
    Dinarti LK; Anggrahini DW; Lilyasari O; Siswanto BB; Hartopo AB
    Glob Heart; 2021 Apr; 16(1):23. PubMed ID: 34040936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.